Allozymes

Evolving Biology, Advancing Tomorrow

Singapore, Singapore · Founded 2019 · $20.0M raised

Headquarters
Singapore
Employees
11–50
Founded
2019
Business Model
B2B
Total Funding
$20.0M
Last Round
$15.0M Series AMay 2024
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Allozymes is a Singapore-based biotechnology company that applies its proprietary ZymeLeap™ ultra-high-throughput microfluidics platform to engineer and discover superior enzymes for oligonucleotide therapeutic manufacturing and industrial biocatalysis applications. Founded in 2019 by Dr. Peyman Salehian and Dr. Akbar Vahidi, the company can test up to 10 million enzyme variants per day using miniaturized microfluidic droplets, dramatically compressing timelines for enzyme development from years to months. Allozymes serves pharma and biotech customers developing siRNA, ASO, and other RNA/DNA therapies, offering both a growing commercial enzyme portfolio and bespoke enzyme engineering services through long-term collaborative partnerships. The company raised a $15 million Series A in 2024 to expand its global presence and scale its enzyme pipeline.

Summary

Allozymes is a Biotech company based in Singapore, Singapore, founded in 2019. It has raised $20.0M in total across 2 rounds, most recently a $15.0M Series A round in May 2024. Investors include Xora Innovation, Seventure Partners and SOSV.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AMay 2024
$15.0M

Sign up to see all 2 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Allozymes on Indexed.vc
<a href="https://indexed.vc/companies/allozymes"><img src="https://indexed.vc/api/badge/company/allozymes" alt="Allozymes on Indexed.vc" width="260" height="76" /></a>